To support community rheumatologists, CSRO has engaged Mark Watson, a healthcare attorney with Hancock, Daniel & Johnson, P.C. to provide a general overview of an agreement proposed by Prime Therapeutics. A webinar was hosted on November 6, 2023, to review the written summary and answer follow up questions.
Disclaimer: CSRO is providing this educational event as a resource but cannot provide advice to individual practices. Each practice should consult with its advisors and make its own, independent assessment and decision on whether to join the IntegratedRx®- Medical network. Each practice should also avoid sharing its decision on whether to join the network with CSRO or other practices. Note that if independent practices discuss the terms of the draft agreement with each other or coordinate their responses to Prime Therapeutics, such activities could raise antitrust concerns.